The infusion of strategic capital could speed time‑to‑market for Polyembo’s products, positioning the company to capture growth in the expanding minimally invasive vascular market and potentially attract further partnerships or acquisitions.
Polyembo, a Longmont, CO-based medical device company, has closed a new funding round led by a multinational strategic investor. The amount was not disclosed; proceeds will be used to advance product development and regulatory clearances.
Comments
Want to join the conversation?
Loading comments...